The Board of the IQM-CSIC Institute, celebrated on April 19, 2023 agrees to open the period for the presentation of candidacies to the Directorate of the IQM-CSIC institute, which will be open until May 27, 2023.
Twitter IQM:
@IQM_CSIC
Publications
- Molina-Álvarez, M, Arribas-Romano, A, Rodríguez-Rivera, C, García, MM, Fernández-Carnero, J, Armijo-Olivo, S et al.. Reply to Rossettini et al. "Do Not Mix Apples with Oranges" to Avoid Misinterpretation of Placebo Effects in Manual Therapy: The Risk Is Resulting in a Fruit Basket. Comment on "Molina-Álvarez et al. Manual Therapy Effect in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2022, 19, 14021". Int J Environ Res Public Health. 2023;20 (15):. doi: 10.3390/ijerph20156445. PubMed PMID:37568987 PubMed Central PMC10419206.
- Oteo-Álvaro, Á, García, CG, Sánchez, AI, Santamaria, CA, de Diego-Adeliño, J. Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). Osteoporos Int. 2023;34 (10):1799-1804. doi: 10.1007/s00198-023-06838-z. PubMed PMID:37405407 .
- Romero-Miguel, D, Casquero-Veiga, M, Fernández, J, Lamanna-Rama, N, Gómez-Rangel, V, Gálvez-Robleño, C et al.. Maternal Supplementation with N-Acetylcysteine Modulates the Microbiota-Gut-Brain Axis in Offspring of the Poly I:C Rat Model of Schizophrenia. Antioxidants (Basel). 2023;12 (4):. doi: 10.3390/antiox12040970. PubMed PMID:37107344 PubMed Central PMC10136134.
